Firms
Theme

APP

Applovin Corporation Class A · NASDAQ

News

20 latest

GlobeNewswire Inc.

Kaplan Fox Urges AppLovin Corporation (NASDAQ: APP) Investors Seeking Recovery to Contact the Firm Before November 16, 2026

Kaplan Fox has filed a class action lawsuit against AppLovin Corporation on behalf of investors who purchased securities between February 12, 2026 and August 5, 2026. The complaint alleges that AppLovin made false statements about its generative AI video creative feature, which faced significant development delays, and overstated improvements to its AI models. The stock declined 12.65% on July 13, 2026 following analyst concerns, and another 19.66% on August 6, 2026 after the company reported below-consensus revenue and revealed its AI video tool was still a work in progress.

GlobeNewswire Inc.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APP

Rosen Law Firm is notifying investors in AppLovin Corporation, Beta Bionics, Inc., and Netcapital Inc. about ongoing securities class action lawsuits. AppLovin investors who purchased shares between February 12, 2026 and August 5, 2026 must act by November 16, 2026 deadline. The lawsuit alleges AppLovin made false statements about AI video features, overstated AI model improvements, and misrepresented the benefits of its AI platform's 'virtuous cycle' value proposition.

Zacks Investment Research

AppLovin (APP) Beats Stock Market Upswing: What Investors Need to Know

AppLovin (APP) outperformed the broader market on October 19, 2026, gaining 1.05% to close at $268.92, ahead of the S&P 500's 0.41% gain. The company is expected to report earnings on November 4, 2026, with forecasted EPS of $3.95 (up 61.22% YoY) and revenue of $2.08 billion (up 47.78% YoY). However, AppLovin holds a Zacks Rank #4 (Sell) rating and trades at a premium valuation with a Forward P/E of 16.98 versus the industry average of 15.84.

Zacks Investment Research

AppLovin Corporation (APP) is Attracting Investor Attention: Here is What You Should Know

AppLovin (APP) has attracted investor attention despite a -13.6% decline over the past month, outpacing the Technology Services industry's -8.1% loss. While the company shows strong fundamentals with expected earnings growth of +56.1% for the current fiscal year and revenue growth of +39.1%, the Zacks Rank #4 (Sell) rating suggests the stock may underperform the broader market in the near term. The company's valuation is rated C, indicating it trades at par with peers.

GlobeNewswire Inc.

ROSEN, RECOGNIZED TRIAL ATTORNEYS, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL

Rosen Law Firm has filed securities class action lawsuits against Anavex Life Sciences Corp. (AVXL) for allegedly making false statements about internal controls and regulatory challenges related to former CEO misconduct. Similar lawsuits have been filed against AppLovin Corporation (APP) and Unicycive Therapeutics, Inc. (UNCY). Investors have until November 30, 2026 to become lead plaintiffs.

GlobeNewswire Inc.

ROSEN, A LEADING LAW FIRM, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APP

Rosen Law Firm is urging AppLovin Corporation investors who purchased securities between February 12, 2026 and August 5, 2026 to join a securities class action lawsuit. The lawsuit alleges that AppLovin made false statements regarding its generative AI video creative feature, overstated AI model improvements, and misrepresented the benefits of its 'virtuous cycle' value proposition. The lead plaintiff deadline is November 16, 2026.

GlobeNewswire Inc.

APP Investors Have Opportunity to Lead AppLovin Corporation Securities Fraud Lawsuit with SBS Law

Schall, Brown & Schwartz LLP announced a class action lawsuit against AppLovin Corporation for securities violations. The lawsuit alleges the company made false and misleading statements about its generative AI video tool, overstated AI model improvements, and exaggerated benefits of its 'virtuous cycle' AI system. The class period spans February 12, 2026 to August 5, 2026, with a deadline of November 16, 2026 for investors to participate.

GlobeNewswire Inc.

ROSEN, A LONGSTANDING FIRM, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APP

Rosen Law Firm has filed securities class action lawsuits against AppLovin Corporation, Lincoln Educational Services Corporation, and Beta Bionics, Inc. The AppLovin lawsuit alleges the company made false statements regarding AI video creative features and overstated the benefits of its AI models. Investors who purchased securities during specified class periods are encouraged to seek counsel before upcoming lead plaintiff deadlines.

Zacks Investment Research

AppLovin (APP) Falls More Steeply Than Broader Market: What Investors Need to Know

AppLovin stock declined 2.28% on October 12, 2026, underperforming the broader market. The mobile app technology company has dropped 14.48% over the past month, significantly lagging the S&P 500's 2.36% gain. Despite strong earnings growth forecasts (61.22% EPS growth expected), AppLovin holds a Zacks Rank #4 (Sell) rating and trades at a premium valuation with a Forward P/E of 17.62 versus its industry average of 15.88.

GlobeNewswire Inc.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APP

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against AppLovin Corporation (NASDAQ: APP) on behalf of investors who purchased securities between February 12, 2026 and August 5, 2026. The lawsuit alleges that AppLovin made false and misleading statements regarding its generative AI video creative feature, overstating AI model improvements and the benefits of its 'virtuous cycle' value proposition. The lead plaintiff deadline is November 16, 2026.

Zacks Investment Research

APP Stock Sinks 53% in a Year: Is it Time to Sell the Stock?

AppLovin (APP) shares have plunged 53% over the past year despite Q2 revenue surging 53% to $1.92B. The company faces significant headwinds including declining advertising-driven installations (-2%), uneven AI model upgrades, rising infrastructure costs, and an unproven consumer advertising business. Legal disputes and intensifying competition add further uncertainty. Analysts recommend selling APP stock rather than betting on an uncertain turnaround.

GlobeNewswire Inc.

APP Investors: AppLovin Corporation Shares Declined By $82.13 On August 6, 2026 -- Contact Kirby McInerney LLP to Discuss Your Rights

A securities fraud class action lawsuit has been filed against AppLovin Corporation for allegedly making false statements about its generative AI video creative feature and overstating the benefits of its AI models. The company's stock declined significantly following disappointing Q2 2026 earnings and revelations that its AI video tool remained incomplete, with investors having until November 16, 2026 to request lead plaintiff status.

Zacks Investment Research

AppLovin (APP) Stock Falls Amid Market Uptick: What Investors Need to Know

AppLovin stock declined 1.13% to $278.78 while broader markets gained, falling 12.04% over the past month. Despite strong earnings growth projections (61.22% EPS growth and 47.82% revenue growth expected), the company holds a Zacks Rank #4 (Sell) rating and trades at a premium valuation with a Forward P/E of 17.94 versus its industry average of 15.83.

GlobeNewswire Inc.

Beneficient Investor News: If You Have Suffered Losses in Beneficient, You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities class action claims against multiple companies including Beneficient (NASDAQ: BENF), J.B. Hunt Transport Services, and AppLovin Corporation (NASDAQ: APP) for allegedly issuing materially misleading business information to investors. The firm is preparing class actions to seek recovery of investor losses on a contingency fee basis.

GlobeNewswire Inc.

ROSEN, LEADING INVESTOR COUNSEL, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APP

Rosen Law Firm is urging AppLovin Corporation investors who purchased securities between February 12, 2026 and August 5, 2026 to join a class action lawsuit. The lawsuit alleges that AppLovin made false statements about its generative AI video creative feature, overstated AI model improvements, and misrepresented the benefits of its 'virtuous cycle' value proposition. The lead plaintiff deadline is November 16, 2026.

Zacks Investment Research

AppLovin Corporation (APP) is Attracting Investor Attention: Here is What You Should Know

AppLovin (APP) has attracted investor attention despite a -12% stock decline over the past month. While the company shows strong earnings growth (+56.6% YoY for current fiscal year) and revenue growth (+39.5%), it received a Zacks Rank #4 (Sell) rating due to recent negative revisions in consensus estimates. The stock is trading at par with peers based on valuation metrics, suggesting potential underperformance in the near term.

GlobeNewswire Inc.

Kaplan Fox Alerts Investors of AppLovin Corporation (NASDAQ: APP) to a Pending Securities Class Action – Deadline is November 16, 2026

A securities class action lawsuit has been filed against AppLovin Corporation for investors who purchased securities between February 12, 2026 and August 5, 2026. The complaint alleges the company made false statements about its generative AI video creative feature experiencing significant development delays and overstated improvements to its AI models.

GlobeNewswire Inc.

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APP

Rosen Law Firm is soliciting investors who purchased AppLovin Corporation (NASDAQ: APP) securities between February 12, 2026 and August 5, 2026 to join a class action lawsuit. The lawsuit alleges that AppLovin made false statements regarding its generative AI video creative feature, overstated AI model improvements, and misrepresented the benefits of its 'virtuous cycle' value proposition. The lead plaintiff deadline is November 16, 2026.

Zacks Investment Research

AppLovin (APP) Declines More Than Market: Some Information for Investors

AppLovin (APP) declined 4.98% on September 30, 2026, underperforming the S&P 500's 0.25% loss. Despite the daily decline, the company maintains strong growth forecasts with expected EPS of $3.95 (up 61.22% YoY) and revenue of $2.08 billion (up 47.82% YoY). AppLovin holds a Zacks Rank #3 (Hold) with a Forward P/E of 19.39, trading at a premium to its industry average.

Zacks Investment Research

ARM vs. APP: Which AI-Exposed Tech Stock to Consider Right Now?

AppLovin (APP) and Arm Holdings (ARM) are both AI-focused technology companies, but AppLovin appears more attractive at current valuations. APP posted 52.4% revenue growth and 66.4% EPS growth in Q2, with 2026 estimates showing 40% sales and 57% EPS growth.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $APP · 0 threads

Sign in to post on $APP

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev